Phlo Corporation (Pink Sheets: PHCP) (the "Company") announced today that the market penetration in Northern California of its vitality beverage, AQISS(TM), will be significantly expanded with the help of Morris Distributing, one of the largest specialty beverage distributors in the San Francisco Bay Area.
CyberKnife Centers of Miami and Palm Beach will be joined by a third, CyberKnife Center of Tampa Bay by summer's end. MORSE LLC of Miami, a world renowned image guided robotic radiosurgery practice facilitator, will guide the three centers in maintaining the model of community-based outpatient cancer treatment facilities. The mission of MORSE LLC is to provide the CyberKnife technology to the broadest number of patients and physicians. A fourth center is in the planning stages in Southwest Florida beginning this fall.
Is it possible that one of nature's most potent superfoods, available since ancient times, has gone mostly unnoticed by the modern world? The answer, surprisingly, seems to be yes.
A Miami-area doctor was sentenced to 41 months in prison for her role in schemes to defraud the Medicare program, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Attorney R. Alexander Acosta of the Southern District of Florida announced today.
Bioheart, Inc., (Nasdaq: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, announced today that Doug Owens, Director, Clinical Affairs, will assume responsibility for Bioheart's regulatory and clinical strategy for its investigational MyoCell(R) Therapy clinical trials from Richard T. Spencer, IV, who served as Bioheart's Vice President, Clinical Affairs and Physician Relations. Spencer has decided to leave Bioheart to pursue other opportunities, but has agreed to be available through the end of August to consult with Bioheart on the sale and distribution of the Bioheart 3370 Heart Failure Monitor as well as ongoing clinical trial activities.
Hoana Medical, Inc. announced today a partnership with a large healthcare system in Pennsylvania, the Veterans Administration (VA) with VA hospitals in Florida and Nebraska, and the U.S. Army to improve patient safety in acute-care hospitals. Hospital experience has shown that rapid response teams (RRT) are not effective if the patient is found too late -- many times patients are found deceased, also referred to as a "dead in bed."
Pilgrim Software, Inc., a world-leading provider of Enterprise Compliance and Quality Management (ECQM) software solutions, today announced that Cepheid, an on-demand molecular diagnostics company based in Sunnyvale, CA, has selected Pilgrim's SmartCAPA(TM) and SmartComplaints(TM) solutions for tracking and managing its Complaints and CAPA processes across all Cepheid divisions worldwide.
Hundreds of thousands of Florida seniors could lose important benefits and pay more out of pocket for health care, while thousands more could lose their Medicare Advantage plan altogether under legislation approved this week by the U.S. Congress.
Vascular Technologies, Inc. is one of the fastest growing medical device companies in the United States. Its principal product is the breakthrough Ultroid(R) Medical System, a less expensive and more effective treatment than current procedures for the treatment of hemorrhoids with new applications for other varicose and spider veins. Ultroid(R) is a painless, non-invasive outpatient treatment with an over 90% effectiveness rate that replaces ineffective over-the-counter creams and painful surgeries that can be accompanied by infection and prolonged recovery. The Ultroid(R) procedure can be performed by any physician, regardless of specialty, in their office, in approximately 10-15 minutes. Patients are able to resume their normal daily activities immediately, versus the several month recovery often associated with current laser and other surgical treatments. Ultroid(R) is FDA-cleared and accepted by most insurers and Medicare.
Synovics Pharmaceuticals, Inc. (OTC Bulletin Board: SYVC), a specialty pharmaceutical company, today announced that Mr. Jyotindra Gange, has been appointed Principal Executive Officer of the Company and in such capacity given the responsibility of overseeing all executive functions. Mr. Gange is currently a member of Synovics' board of directors and is the Chief Financial Officer of Maneesh Pharmaceuticals, LTD., a leading privately held pharmaceutical company based in India and a joint venture partner with Synovics. Maneesh Pharmaceuticals LTD. is a significant investor in Synovics Pharmaceuticals, Inc. Previously, Mr. Gange served as Chief Financial Officer of Multi Arc India Ltd., a provider of industrial coatings and Bharat Serums and Vaccines Ltd., an Indian pharmaceuticals company. Mr. Gange was also Vice President - Finance at Universal Ferrous Ltd., a producer of ferro alloys. Mr. Gange is a Chartered Accountant in India. Ronald Howard Lane, Ph.D., resigned as the Company's Chief Executive Officer and will remain as its Chairman of the Board.
Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL) (the "Company"), one of the world's largest and most established family cord blood banks, today announced results for the second quarter and six months ended May 31, 2008.
When the American Academy of Pediatrics (AAP) issued its recommendation on July 7 regarding the treatment of children with high cholesterol, it generated a strong response from the community of medical professionals and patients. The National Lipid Association (NLA), a group of healthcare professionals who specialize in cholesterol and heart disease issues, believes that the AAP has acted in the interests of patient care by raising the issue of lipid abnormalities in children.
Bioheart, Inc. (Nasdaq: BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, today announced it has secured worldwide non-exclusive distribution rights to the Bioheart 3370 Heart Failure Monitor, an interactive and simple-to-use at-home intelligent device designed specifically to improve available healthcare to patients outside hospitals who are suffering from heart failure. The device, manufactured by RTX Healthcare A/S (Denmark), has 510k market clearance from the US Food and Drug Administration for marketing in the U.S. and CE mark approval for marketing in Europe and other countries that follow this mark. The Company is planning to begin immediate commercial distribution.
The National Association of Neonatal Nurses (NANN) is pleased to announce the inaugural recipients of the OVATION Neonatal Nursing Career Path Scholarship program made possible through a grant from OVATION Pharmaceuticals, Inc. The program supports and encourages the training and education of clinical neonatal nurses seeking to become neonatal nurse practitioners. Scholarships will be awarded to two recipients, Janet Robnett, R.N.C., of Charlotte, N.C., and Ashley Darcy, B.S.N., R.N., of Philadelphia, Pa., during the NANN annual meeting to be held in Ft. Lauderdale, Fla., September 24-27, 2008.
VideoMD announces the launch of VideoMD.com, a new website that focuses on physician generated video health information. The site is a video sharing site that helps doctors educate their own patients by uploading educational videos to their individual page of VideoMD. Patients then search for their doctor by name.
CSX Transportation (CSXT) is helping focus national attention on the need to address and upgrade America's transportation infrastructure in an environmentally responsible manner so the nation can better compete in the changing global economy, two of its officials told public and private sector representatives attending the Faster Freight- Cleaner Air (FFCA) East Coast conference in New York City this week. CSXT is a platinum sponsor of FFCA, the nation's leading conference on goods movement and air quality.
While consumers are aware of the dangers of extended sun exposure and its effects on the skin, many are not aware that the eyes are also at great risk. A survey conducted by the New England Eye Institute and Transitions Optical found that nearly 80 percent of consumers report knowing that UV exposure can cause skin cancer, but only five percent are aware that it can harm the eyes.
Gonzaba Medical Group, a multi-site medical practice with 20 physicians, has selected Intergy EHR by Sage Electronic Health Records and Intergy by Sage Practice Management (PM) system to provide its newest San Antonio-based clinic with seamless access to patient and clinical data at all points of care -- without the use of paper charts.
Nyer Medical Group, Inc. (Nasdaq: NYER) announced that it has sold ADCO South Medical Supplies, Inc., ("ADCO South") its Florida Medical-Surgical division. Nyer further announced that its pharmacy division, D.A.W. Inc., was awarded a two-year contract with Sunrise Senior Living, Inc. to be the preferred pharmacy provider at all 16 of the company's Assisted Living Facilities in Massachusetts. The award was made at the conclusion of a competitive proposal submission and review process. Residents at the facilities approximate 1,600.
minSURG(TM) Corporation, through its parent company, Orthopedic Development Corporation, has received a Notice of Allowance from the United States Patent and Trademark Office on two of its pending US patent applications. The patents protect the designs of one of its TruFUSE(R) dowels and a Surgical Drill Guide, which is used in minSURG's proprietary TruFUSE Minimally Invasive Facet Fusion Procedures and Systems. The pending patents, once issued, will offer patent protection through 2022.
Previous
